KEGG   DRUG: Bismuth subcitrate, tetracycline and metronidazole
Entry
D10245            Mixture   Drug                                   
Name
Bismuth subcitrate, tetracycline and metronidazole;
Helidac (TN);
Pylera (TN)
Product
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE (H2-Pharma), PYLERA (Allergan), PYLERA (H2-Pharma)
  Generic
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (Par Pharmaceutical), BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE (Ingenus Pharmaceuticals)
Component
(Bismuth subcitrate [DR:D07587] | Bismuth subcitrate potassium [DR:D09739]), Tetracycline hydrochloride [DR:D02122], Metronidazole [DR:D00409]
Remark
ATC code: A02BD08
Product: D10245<US>
Efficacy
Antibacterial
  Disease
Helicobacter pylori infection [DS:H00320]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A02 DRUGS FOR ACID RELATED DISORDERS
   A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
    A02BD Combinations for eradication of Helicobacter pylori
     A02BD08 Bismuth subcitrate, tetracycline and metronidazole
      D10245  Bismuth subcitrate, tetracycline and metronidazole <US>
USP drug classification [BR:br08302]
 Gastrointestinal Agents
  Gastrointestinal Agents, Other
   Bismuth Subcitrate Potassium/ Metronidazole/ Tetracycline Hydrochloride
    D10245  Bismuth subcitrate, tetracycline and metronidazole
Antimicrobials [BR:br08307]
 Antibacterials
  Protein biosynthesis inhibitor
   Tetracycline
    D10245  Bismuth subcitrate, tetracycline and metronidazole <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10245
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10245
Other DBs
PubChem: 163312276
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system